Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization

Clinical Cancer Research

Volumn 7, Issue 6, 2001, Pages 1676-1682

  Stadler, W M ^a   Steinberg, G ^a   Yang, X ^a   Hagos, F ^a   Turner, C ^a   Olopade, O I ^a  

^a MC2115   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; GENE PRODUCT; PROTEIN DBCCR1; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CHROMOSOME 9P; CHROMOSOME 9Q; CHROMOSOME BAND; CHROMOSOME LOSS; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 9; GENE DELETION; GENES, P16; GENES, P53; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0034907606     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Chromosomal analysis of bladder cancer. III. Nonrandom alterations
2. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9
3. Detailed deletion mapping of chromosome 9q in bladder cancer: Evidence for two tumour suppressor loci
4. Evidence for two bladder cancer suppressor loci on human chromosome 9
5. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations
6. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
7. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
8. The 9p21 region in bladder cancer cell lines: Large homozygous deletion inactivates the CDKN2, CDKN2B, and MTAP genes
9. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer
10. A cell cycle regulator potentially involved in genesis of many tumor types
11. Deletion of the p16 and p15 genes in human bladder tumors
12. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
13. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
14. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
15. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33
16. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer
17. Chromosome 9 loss detected by fluorescence in situ hybridization in bladder cancer
18. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization
19. Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder
20. Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization
21. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis
22. Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer
23. Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization
24. Regulation of genomic instability in preneoplastic cells
25. Overcoming cellular senescence in human cancer pathogenesis
26. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53
27. Increased p16 levels correlate with pRb alterations in human urothelial cells
28. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer
29. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction
30. The prognostic significance of S-phase analysis in stage Ta/T1 bladder cancer - A Southwest Oncology Group Study
31. Prognostic significance of flow cytometric deoxyribonucleic acid analysis for patients with superficial bladder cancers: A long-term follow-up study
32. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH
33. Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy
34. Two molecular pathways to transitional cell carcinoma of the bladder